238 related articles for article (PubMed ID: 2531734)
1. Assay method for single-chain urokinase-type plasminogen activator.
Matsuo O; Ueshima S; Okada K; Fukao H; Ohgaki M; Watanabe R; Arimura H
Hematol Pathol; 1989; 3(3):137-42. PubMed ID: 2531734
[TBL] [Abstract][Full Text] [Related]
2. Differential detection of single-chain and two-chain urokinase-type plasminogen activator by a new immunoadsorbent-amidolytic assay (IAA).
Corti A; Nolli ML; Cassani G
Thromb Haemost; 1986 Dec; 56(3):407-10. PubMed ID: 3105110
[TBL] [Abstract][Full Text] [Related]
3. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein.
Binnema DJ; Dooijewaard G; Turion PN
Thromb Haemost; 1991 Feb; 65(2):144-8. PubMed ID: 1905069
[TBL] [Abstract][Full Text] [Related]
4. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
[TBL] [Abstract][Full Text] [Related]
5. An enzyme-linked immunosorbent assay for urokinase-type plasminogen activator (u-PA) and mutants and chimeras containing the serine protease domain of u-PA.
Declerck PJ; Van Keer L; Verstreken M; Collen D
Thromb Haemost; 1992 Jan; 67(1):95-100. PubMed ID: 1377417
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
Ugwu F; Van Hoef B; Bini A; Collen D; Lijnen HR
Biochemistry; 1998 May; 37(20):7231-6. PubMed ID: 9585535
[TBL] [Abstract][Full Text] [Related]
7. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA).
Nelles L; Lijnen HR; Van Nuffelen A; Demarsin E; Collen D
Thromb Haemost; 1990 Aug; 64(1):53-60. PubMed ID: 2148847
[TBL] [Abstract][Full Text] [Related]
8. Functional assay of plasminogen activator by hydrolysis of 14C-globin.
Finci Z; Nachshon I; Sharoni Y; Mayer M
Exp Hematol; 1986 May; 14(4):293-7. PubMed ID: 2938980
[TBL] [Abstract][Full Text] [Related]
9. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
[TBL] [Abstract][Full Text] [Related]
10. The differential glycosylation of human pro-urokinase from various recombinant mammalian cell lines does not affect activity and binding to PAI-1.
Sarubbi E; Nolli ML; Robbiati F; Soffientini A; Parenti F; Cassani G
Thromb Haemost; 1989 Nov; 62(3):927-33. PubMed ID: 2512681
[TBL] [Abstract][Full Text] [Related]
11. Measurement of urokinase-type plasminogen activator (u-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies.
Darras V; Thienpont M; Stump DC; Collen D
Thromb Haemost; 1986 Dec; 56(3):411-4. PubMed ID: 3105111
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activator.
de Munk GA; Groeneveld E; Rijken DC
Thromb Haemost; 1993 Sep; 70(3):481-5. PubMed ID: 8259553
[TBL] [Abstract][Full Text] [Related]
13. Protection of single-chain urokinase-type plasminogen activator (scu-PA) in aprotinin treated cardiac surgical patients undergoing cardiopulmonary bypass.
Spannagl M; Dooijewaard G; Dietrich W; Kluft C
Thromb Haemost; 1995 May; 73(5):825-8. PubMed ID: 7482410
[TBL] [Abstract][Full Text] [Related]
14. Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR.
Fowler B; Mackman N; Parmer RJ; Miles LA
Thromb Haemost; 1998 Jul; 80(1):148-54. PubMed ID: 9684801
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of fibrinolytic capacity in plasma during thrombolytic therapy with single (scu-PA) or two-chain urokinase type plasminogen activator (tcu-PA) by a combined assay system for urokinase type plasminogen activator antigen and function.
Wojta J; Binder BR; Huber K; Hoover RL
Thromb Haemost; 1989 Apr; 61(2):289-93. PubMed ID: 2501899
[TBL] [Abstract][Full Text] [Related]
16. Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH2-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activator.
Lijnen HR; Nelles L; Van Hoef B; De Cock F; Collen D
Thromb Haemost; 1988 Oct; 60(2):247-50. PubMed ID: 3146141
[TBL] [Abstract][Full Text] [Related]
17. Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells.
van der Kaaden ME; Rijken DC; Groeneveld E; van Berkel TJ; Kuiper J
Thromb Haemost; 1995 Aug; 74(2):722-9. PubMed ID: 8585013
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of plasmin catalyzed conversion of single-chain to two-chain urokinase-type plasminogen activator by sulfated polysaccharides.
Rydzewski A; Takada Y; Takada A
Thromb Haemost; 1989 Sep; 62(2):752-5. PubMed ID: 2479114
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activation with single-chain urokinase-type plasminogen activator (scu-PA). Studies with active site mutagenized plasminogen (Ser740----Ala) and plasmin-resistant scu-PA (Lys158----Glu).
Lijnen HR; Van Hoef B; Nelles L; Collen D
J Biol Chem; 1990 Mar; 265(9):5232-6. PubMed ID: 1969415
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of urokinase plasminogen activator, its receptor, and its inhibitor in patients with renal cell carcinoma.
Hofmann R; Lehmer A; Buresch M; Hartung R; Ulm K
Cancer; 1996 Aug; 78(3):487-92. PubMed ID: 8697395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
